Comments
Commented by André Will-Laudien on May 7th, 2025 | 09:55 CEST
High-grade discovery at Tocvan Ventures – Gold corridor within reach at Gran Pilar
Volatility on the capital markets reached record levels in the first quarter of 2025. Geopolitical upheavals and unpredictable US policy have caused stock prices to fluctuate wildly. Precious metal investments could provide a good hedge against turbulence in the financial system and a devaluation of the US dollar. With spot prices recently reaching new record highs, investors are increasingly strengthening their exposure to the commodities sector. Gold has so far met expectations with prices of up to USD 3,500 and an annual gain of just under 20% in 2025, while silver has also reached high prices of over USD 35. In addition to producers, the spotlight is now shifting to the second tier of explorers. This is because the valuations of in-ground resources are at their lowest level in decades. Canadian gold explorer Tocvan Ventures (CSE: TOC | WKN: A2PE64 | ISIN: CA88900N1050 | CAD 0.69) has recently seen a string of positive announcements. The latest update on recent drilling at the Pilar gold-silver project in Sonora delivered impressive gold and silver grades.
Read
Commented by Armin Schulz on May 7th, 2025 | 07:10 CEST
Evotec's AI gold mine, Defence Therapeutics' billion-dollar markets, Novo Nordisk's diet revolution: How investors are profiting
The healthcare industry is undergoing radical change. Algorithms are accelerating drug discovery by years, billions are being poured into personalized therapies, and biotech stocks are celebrating on the stock markets. But this time, it is not just short-lived hype – the next era of medicine will be shaped by companies merging technology and biology. While AI-based platforms identify drug candidates in record time, pioneers are pushing ahead with groundbreaking approaches in oncology, immunology, and metabolic diseases. Three names stand out: Evotec, Defence Therapeutics, and Novo Nordisk.
Read
Commented by Fabian Lorenz on May 7th, 2025 | 07:05 CEST
While Friedrich Merz fails, BUYING OPPORTUNITIES arise for these stocks: Deutz, BYD, and Power Metallic Mines
Friedrich Merz has failed in the first round of voting to become Chancellor. But these stocks are winners: without metals, there would be no electromobility, no defense, no infrastructure - and when it comes to gold, no store of value. Power Metallic Metals caused a stir last year with spectacular drilling results. The latest samples show that the potential is far from exhausted. The current consolidation of the stock should soon be over. Deutz has already demonstrated how quickly a stock can explode. Analysts believe there is even more upside potential! And what is BYD doing? The Chinese company is growing strongly in their home market. In Europe, a bestseller is now set to bring success. Is this a threat to Volkswagen?
Read
Commented by Nico Popp on May 7th, 2025 | 07:00 CEST
Will dynaCERT save German industry?
The future is traded on the stock market. However, while prototypes and small-scale production fuel investor imagination, only concrete orders generate profits. Canadian hydrogen company dynaCERT is currently in an exciting phase. The Company went on a customer acquisition drive at the Munich construction and mining trade fair (Bauma). Find out what events are planned for the coming weeks and months and which industries, particularly in Germany, are being considered potential partners for dynaCERT.
Read
Commented by Nico Popp on May 6th, 2025 | 07:10 CEST
Almonty: Why tungsten is the most critical of all metals
Tungsten producer Almonty Industries shares are among this year's high flyers - rising from EUR 0.61 to EUR 1.56. There are many reasons for this: the imminent opening of Almonty's Sangdong mine in South Korea comes at a time of extreme geopolitical volatility, including a tariff and raw materials war and the gradual erosion of NATO. However, there are further reasons why tungsten is currently in such high demand. What role does China play in this, and do stocks like Almonty still hold more upside potential?
Read
Commented by Armin Schulz on May 6th, 2025 | 07:05 CEST
Soil boosters wanted! The secret weapons of Bayer, Argo Living Soils, and K+S
Agriculture is at a crossroads between tradition and revolution. While optimistic forecasts like the Iowa Crop Progress Report 2025 predict record-breaking harvests, a paradoxical conflict is emerging. Blooming fields conceal depleting soils and climate stress. But this is precisely where the tension for innovation unfolds - where high-tech meets sustainability. Three players are helping to shape this future: Bayer as a pioneer of digital agricultural solutions; Argo Living Soils with revolutionary soil savers; and K+S, which is rethinking mineral fertilizers. Together, they are not only securing harvests but also healing ecosystems.
Read
Commented by Stefan Feulner on May 6th, 2025 | 07:00 CEST
Strategy, 123fahrschule, BASF – Massive increases
Amid high volatility, Germany's leading index, the DAX, regained the psychologically important 23,000-point mark after its setback in April. Investors are betting on an imminent resolution to US President Donald Trump's erratic tariff policies. Small caps also posted significant gains after the drastic losses in the previous month. Many companies remain undervalued, offering further upside potential.
Read
Commented by André Will-Laudien on May 5th, 2025 | 07:20 CEST
Biotech is back with artificial intelligence! Evotec, NetraMark Holdings, Bayer, and BioNTech
Artificial intelligence has arrived in health research! Whenever large volumes of data need to be analyzed, patterns recognized, or results condensed, immense computing power is required. The goal is to detect complex structures, automate processes, and make real-time decisions. The use of AI in medicine and pharmaceutical development is making good progress because time and high validation capability are key here. Some companies have already recognized the signs of the times and are working hard on the new technologies. On the stock market, this is often the starting signal for significantly higher valuations. Evotec, Bayer, and BioNTech are well-known European players, while Canadian company NetraMark Holdings has seen its share price increase sevenfold since fall 2024. What is behind this surge?
Read
Commented by Armin Schulz on May 5th, 2025 | 07:15 CEST
How Palantir, MiMedia Holdings, and SAP are transforming the cloud into trillion-dollar markets
The cloud is the invisible titan of the digital economy. It drives innovation, breaks efficiency barriers, and is expected to generate over USD 800 billion in 2025 alone. But behind the scenes, tech pioneers are shaping the rules of this billion-dollar market. With AI-driven forecasts, disruptive data storage solutions, and cloud-based ecosystems, they are deciding who will dominate the era of hyperdigitalization. While companies are fiercely competing for agility and scale in the race for the cloud strategies of the future, three players are setting the standard with technologies that are changing not only markets but also mindsets. A look at Palantir, MiMedia Holdings, and SAP reveals what makes them different from the rest.
Read
Commented by Nico Popp on May 5th, 2025 | 07:10 CEST
Lithium Made in Europe: European Lithium, SQM, Stellantis, and the supply chains of the future
Electromobility is booming - but without lithium, there are no batteries, and without batteries, there is no mobility transition. While major corporations like SQM from Chile dominate the market, European Lithium is working to make Europe more independent. At the same time, manufacturers such as Stellantis are establishing local supply chains to decouple themselves from global supply risks. We outline the situation in the lithium market and take a European perspective.
Read